Trial Profile
A Prospective, Randomised, Vehicle-Controlled, Double-Blind, Exploratory Clinical Trial To Assess The Efficacy And Steroid Sparing Potential Of DGLA Cream Topically Applied To Patients With Moderate To Severe Atopic Dermatitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Sep 2018
Price :
$35
*
At a glance
- Drugs Diroleuton (Primary)
- Indications Atopic dermatitis
- Focus Proof of concept; Therapeutic Use
- Sponsors DS Biopharma
- 17 Sep 2018 Status changed from planning to completed.
- 24 Mar 2015 This trial is expected to start recruiting in May 2015, and results are expected to be reported by the end of 2015, according to a Dignity Sciences media release.
- 24 Mar 2015 New trial record